Merck Transforms Through Acquisitions Ahead of Keytruda Patent Expiry

Pharmaceutical giant Merck is undergoing a transformation driven by strategic acquisitions as it prepares for the upcoming patent expiration of its top-selling cancer drug, Keytruda.

14 Apr, 10:00 — 14 Apr, 10:00

Post Share

Sources

Showing 1 of 1 sources

FTVery High125d ago

Merck transforms itself through dealmaking as clock ticks on top-selling drug

Acquisitions fuel pharma group’s evolution as it prepares to lose patent protection on cancer drug Keytruda

Read full article →

PERSPECTA

PERSPECTA

Merck Transforms Through Acquisitions Ahead of Keytruda Patent Expiry

Sources

Merck transforms itself through dealmaking as clock ticks on top-selling drug

Related Stories

Study Reveals Elderly More Vulnerable to Extreme Heat Than Previously Thought

Nollywood Actor Ogogo Hassan's Daughters Seek Help for Father's Stage 4 Cancer

Cancer Survivor Erin Races Against Time for Chance of Motherhood

West Nile Fever Spreads in North Macedonia and Serbia, Causing Deaths

PERSPECTA